Universe Pharmaceuticals INC
UPC
$4.20
$0.4010.53%
NASDAQ
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.39M | 11.39M | 18.50M | 18.50M | 26.27M |
| Total Receivables | 14.38M | 14.38M | 10.73M | 10.73M | 17.52M |
| Inventory | 3.39M | 3.39M | 3.34M | 3.34M | 3.08M |
| Prepaid Expenses | 4.00M | 4.00M | 4.05M | 4.05M | 2.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 369.00K | 369.00K | 180.60K | 180.60K | 3.64M |
| Total Current Assets | 33.53M | 33.53M | 36.81M | 36.81M | 52.52M |
|
|
|||||
| Total Current Assets | 33.53M | 33.53M | 36.81M | 36.81M | 52.52M |
| Net Property, Plant & Equipment | 3.52M | 3.52M | 3.70M | 3.70M | 4.14M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 147.70K | 147.70K | 148.60K | 148.60K | 160.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.54M | 11.54M | 11.94M | 11.94M | 12.82M |
| Total Assets | 49.43M | 49.43M | 53.29M | 53.29M | 70.37M |
|
|
|||||
| Total Accounts Payable | 7.76M | 7.76M | 4.59M | 4.59M | 11.24M |
| Total Accrued Expenses | 2.90M | 2.90M | 3.15M | 3.15M | 2.16M |
| Short-term Debt | 4.43M | 4.43M | 5.48M | 5.48M | 4.08M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 5.52M | 5.52M | 540.10K | 540.10K | 5.77M |
| Total Other Current Liabilities | 5.52M | 5.52M | 540.10K | 540.10K | 5.77M |
| Total Current Liabilities | 20.61M | 20.61M | 13.75M | 13.75M | 23.24M |
|
|
|||||
| Total Current Liabilities | 20.61M | 20.61M | 13.75M | 13.75M | 23.24M |
| Long-Term Debt | 2.08M | 2.08M | -- | -- | -- |
| Short-term Debt | 4.43M | 4.43M | 5.48M | 5.48M | 4.08M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.69M | 22.69M | 13.75M | 13.75M | 23.24M |
|
|
|||||
| Common Stock & APIC | 29.35M | 29.35M | 29.35M | 29.35M | 29.35M |
| Retained Earnings | -502.60K | -502.60K | 12.60M | 12.60M | 18.05M |
| Treasury Stock & Other | -2.10M | -2.10M | -2.41M | -2.41M | -266.90K |
| Total Common Equity | 26.74M | 26.74M | 39.53M | 39.53M | 47.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.74M | 26.74M | 39.53M | 39.53M | 47.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.74M | 26.74M | 39.53M | 39.53M | 47.13M |
|
|
|||||